Brainstorm Cell Therapeutics(BCLI) - 2024 Q4 - Annual Results
Brainstorm Cell Therapeutics(BCLI)2025-03-31 11:10Exhibit 99.1 BrainStorm Cell Therapeutics Announces Full Year 2024 Financial Results and Provides Corporate Update Conference call and webcast at 8:30 a.m. Eastern Time today NEW YORK, March 31, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the fiscal year ended December 31, 2024, and provided a corporate update. "2024 was a year of resilience and progress for Br ...